POLYSORBATE 20: 59 Adverse Event Reports & Safety Profile
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
59
Total FAERS Reports
0
Deaths Reported
55
Hospitalizations
59
As Primary/Secondary Suspect
42
Life-Threatening
2
Disabilities
First Report: 20180226 · Latest Report: 20230201
What Are the Most Common POLYSORBATE 20 Side Effects?
#1 Most Reported
Fall
47 reports (79.7%)
#2 Most Reported
Cognitive disorder
47 reports (79.7%)
#3 Most Reported
Pain
46 reports (78.0%)
All POLYSORBATE 20 Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cognitive disorder | 47 | 79.7% | 0 | 47 |
| Fall | 47 | 79.7% | 0 | 47 |
| Balance disorder | 46 | 78.0% | 0 | 46 |
| Blood calcium decreased | 46 | 78.0% | 0 | 46 |
| Constipation | 46 | 78.0% | 0 | 46 |
| Creatinine renal clearance decreased | 46 | 78.0% | 0 | 46 |
| Depressed level of consciousness | 46 | 78.0% | 0 | 46 |
| Hypotension | 46 | 78.0% | 0 | 46 |
| Mobility decreased | 46 | 78.0% | 0 | 46 |
| Orthostatic hypotension | 46 | 78.0% | 0 | 46 |
| Pain | 46 | 78.0% | 0 | 46 |
| Sedation complication | 41 | 69.5% | 0 | 41 |
| Sedation | 40 | 67.8% | 0 | 40 |
| Toxicity to various agents | 40 | 67.8% | 0 | 40 |
| Drug interaction | 34 | 57.6% | 0 | 34 |
| Dyspnoea | 34 | 57.6% | 0 | 34 |
| Renal function test abnormal | 34 | 57.6% | 0 | 34 |
| Drug abuse | 31 | 52.5% | 0 | 31 |
| Overdose | 31 | 52.5% | 0 | 31 |
| Off label use | 30 | 50.9% | 0 | 30 |
Who Reports POLYSORBATE 20 Side Effects? Age & Gender Data
Gender: 96.2% female, 3.8% male. Average age: 75.8 years. Most reports from: CA. View detailed demographics →
Is POLYSORBATE 20 Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 0 |
What Is POLYSORBATE 20 Used For?
| Indication | Reports |
|---|---|
| Insomnia | 49 |
| Product used for unknown indication | 9 |
Official FDA Label for POLYSORBATE 20
Official prescribing information from the FDA-approved drug label.